Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. III. Class II furcations after 10 years

被引:46
|
作者
Eickholz, Peter
Pretzl, Bernadette
Holle, Rolf
Kim, Ti-Sun
机构
[1] Univ Hosp Frankfurt, Ctr Dent Oral & Maxillofacial Med, Dept Periodontol, Frankfurt, Germany
[2] Univ Hosp Heidelberg, Ctr Dent Oral & Maxillofacial Med, Dept Conservat Dent, Sect Periodontol, Heidelberg, Germany
[3] GSF Natl Res, Ctr Environm & Hlth, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany
关键词
furcation defects/therapy; guided tissue regeneration; membranes; artificial; polytetrafluoroethylene/therapeutic use;
D O I
10.1902/jop.2006.77.1.88
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The aim of this 10-year follow-up was to evaluate the long-term results after guided tissue regeneration (GTR) therapy of Class II furcation defects using non-resorbable and bioabsorbable barriers clinically. Methods: In nine patients with advanced periodontitis, nine pairs of contralateral Class 11 furcation defects were treated. Within each patient, one defect received a non-resorbable expanded polytetrafluoroethylene barrier (ePTFE; C) and the other a bioabsorbable (polyglactin 910; T) barrier by random assignment. At baseline and 12 and 120 6 months after surgery, clinical parameters were obtained. Results: Twelve and 120 months after GTR therapy, statistically significant (P < 0.05) horizontal clinical attachment level (CAL-H) gain was observed in both groups (C12: 1.9 +/- 0.5 mm; C120: 1.1 +/- 1.3 mm; T12: 1.9 +/- 0.8 mm; T120: 1.7 +/- 1.4 mm). However, one patient with furcations that had been assessed as Class 1 12 months after GTR therapy had lost two teeth after 10 years, and another patient had lost more than 2 mm CAL-H at one furcation from 12 to 120 6 months post-surgery 10 years after implantation of an ePTFE barrier. Horizontal bone sounding revealed similar bone gain in both groups 120 6 months post-surgery (C120: 0.8 1.0 mm; T120: 1.1 1.1 mm). Conclusions: CAL-H gain achieved after GTR therapy in Class 11 furcations was stable after 10 years in 15 of 18 defects (83%). The study failed to show a statistically significant difference in stability of CAL-H gain between group C and T 10 years after GTR therapy.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 31 条
  • [31] Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation Paclitaxel-Carboplatin in Stage III Non-small Cell Lung Cancer
    Casas, Francesc
    Vinolas, Nuria
    Ferrer, Ferran
    Agusti, Carles
    Sanchez, Marcelo
    Maria Gimferrer, Josep
    Lomena, Francisco
    Campayo, Marc
    Jeremic, Branislav
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 79 - 85